📰 Nasdaq Sera News
Nasdaq Sera News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Sera. Real-time updates on events, politics, business and more.
April 28, 2024
Marquette Asset Management LLC reduced its holdings in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 9.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 32,139 shares of the company’s stock after selling 3,548 shares during the period. Marquette Asset Management LLC’s holdings in Sera Prognostics were worth $192,000 at […]
April 26, 2024
Acuitas Investments LLC lowered its stake in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 30.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 121,258 shares of the company’s stock after selling 51,937 shares during the period. Acuitas […]
March 29, 2024
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) CEO Zhenya Lindgardt sold 38,899 shares of the business’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $9.37, for a total transaction of $364,483.63. Following the completion of the transaction, the chief executive officer now owns 908,104 shares […]
March 13, 2024
Sera Prognostics (NASDAQ:SERA – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, March 20th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Sera Prognostics Trading Down […]
February 8, 2024
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) General Counsel Benjamin Jackson sold 5,665 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $8.03, for a total value of $45,489.95. Following the transaction, the general counsel now directly owns 152,035 shares […]
February 4, 2024
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) shares were up 8% during mid-day trading on Friday . The stock traded as high as $7.74 and last traded at $7.66. Approximately 295,827 shares were traded during trading, an increase of 13% from the average daily volume of 262,132 shares. The stock had previously closed at […]
October 1, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 148,700 shares, an increase of 31.4% from the August 31st total of 113,200 shares. Currently, 1.1% of the company’s shares are short sold. Based on an […]
July 30, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]
July 28, 2023
Riverview Capital Advisers LLC lifted its holdings in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 5.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,731 shares of the company’s stock after buying an additional 5,563 shares during the quarter. […]
July 28, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]